Sano blog | genetic testing (5)

patient recruitment rare disease genetic testing

Key takeaways from an important conversation about IRD research

On October 18th, 2024 20/20 Onsite, Sano Genetics, and Clinical Enrollment announced the launch of a new partnership to offer a comprehensive solution for ident...

How biotechs can leverage cutting-edge tools and methods to scale precision medicine with limited resources

precision medicine genetic testing

Scaling precision medicine in biotech: Tools & methods

Precision medicine is built on the premise that treatment and prevention strategies should account for individual variability in genes, environment, and lifesty...

biomarkers precision medicine genetic testing

Precision medicine landscape for cardiometabolic conditions

Precision medicine approaches to cardiometabolic conditions are still in their infancy but stand poised to transform treatment approaches and are increasingly r...

Gene and cell therapy: How innovation is changing rare disease treatment

precision medicine rare disease genetic testing

Cell and gene therapy: How innovation is changing rare disease treatment

Cell and gene therapies (CGTs) are reshaping what it means to treat disease. Instead of managing symptoms over a lifetime, these approaches aim to address disea...

genetic testing podcast recap

Podcast recap: Dr. Susan Liebman on genetic testing, advocacy, and the power of storytelling

On a recent episode of The Genetics Podcast, Patrick Short speaks with Dr. Susan Liebman, a professor emerita and researcher, about her personal and professiona...

Jim Wilson on the population genomics of the Scottish islands featured image

genetic epidemiology genetic testing podcast recap

Podcast recap: Dr. Jim Wilson on the genetics of isolated communities

In the latest episode of The Genetics Podcast, Patrick speaks with Dr. Jim Wilson, Professor of Human Genetics at the University of Edinburgh, about his work st...

biomarkers genetic testing neurodegenerative disease

What’s driving progress in precision neurology?

Precision medicine is transforming neurology by enabling more accurate diagnoses and tailored treatments. Here, we explore key components driving this progress,...

industry report rare disease genetic testing

Exploring inherited retinal disorders (IRDs): Causes, challenges, and future treatments [report]

Inherited retinal disorders (IRDs) are a diverse group of genetic eye conditions that impact millions worldwide, affecting light-sensitive cells in the retina a...

rare disease genetic testing

Challenges in developing new therapies for Inherited Retinal Disorders (IRD)

Inherited retinal diseases (IRDs) are a leading cause of genetic vision loss, yet they remain difficult to identify and diagnose. Genetic testing plays a pivota...